Assays and screens; biomarkers

TECHNOLOGY: Cell-free assays; plasma markers

A composite measure of Aβ40, Aβ42 and APP669-711 levels in plasma that determines the brain burden of β amyloid could

Read the full 246 word article

User Sign In